Serious riskFDA DrugClass I

B. Braun sodium chloride injection recalled for particulate matter

B. Braun Medical Inc. is recalling specific lots of 0.9% Sodium Chloride Injection due to the presence of particulate matter, including iron oxide, inorganic material, cellulose fibers, and polystyrene. The contamination was identified during quality testing. This is a sterile injectable product distributed nationwide.

From the FDA notice · Read the official notice ↗ · All B. Braun recalls

What to do

  1. Check if your facility has lots J6B435, J6B444, or J6B457 with expiration date 30 APR 2027.
  2. Do not use affected vials. Quarantine them and contact your supplier or B. Braun Medical Inc. for instructions on return or disposal.
  3. Contact your healthcare provider or pharmacist if this product has already been administered to a patient.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
0.9% Sodium Chloride Injection, USP, 100 mL Partial Fill in 150 mL PAB Container, Sterile, Rx only, B. Braun Medical Inc., Bethlehem, PA 18018 USA, NDC 0264-1800-32.
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Units affected
201,472 total container
Illnesses reported
None reported
Manufactured in
861 Marcon Blvd, Allentown, PA, United States
Classification
Class I
Recall number
D-0869-2026

In the FDA's words

Description
0.9% Sodium Chloride Injection, USP, 100 mL Partial Fill in 150 mL PAB Container, Sterile, Rx only, B. Braun Medical Inc., Bethlehem, PA 18018 USA, NDC 0264-1800-32. Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene Lot #: J6B435, J6B444, J6B457, Exp Date: 30APR2027. Distribution: Nationwide within the United States Affected quantity: 201,472 total container
Hazard
Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene

More from B. Braun

See all

Related topics

ParticulateDrugsSold nationwideMore from FDA Drug